The Brutalist Report - business
- NAB Flags Higher Costs as Credit Impairments Hit Profit [164d]
- BlueScope Steel full-year profit tumbles 90% on North America impairment [164d]
- Massive Headwinds Are on the Horizon for Pharmaceutical Stocks, but Here Are 2 That Could Weather the Storm [164d]
- 5 High-Quality Dividend Stocks Yielding Well Over 5% to Buy Without Hesitation Right Now [164d]
- George Kamel: 6 Things Poor People Waste Money On [164d]
- 5 Dividend Stocks to Hold for the Next 5 Years [164d]
- Klook taps banks for US IPO, sources say [164d]
- Prediction: This Unstoppable Stock Will Be a Founding Member of the $6 Trillion Club by 2027 [164d]
- Should You Buy Broadcom Stock Before Sept. 4? Here's What the Evidence Suggests. [164d]
- Clover Health (CLOV) Achieves Profitability as Medicare Advantage Membership Surges [164d]
- Salesforce (CRM) Price Target Cut to $325 — But Stifel Stays Bullish [164d]
- GoodRx (GDRX) Lifts Guidance as Pharma Partnerships Drive Double-Digit Growth [164d]
- Why Wells Fargo Is Confident in Micron’s (MU) HBM Growth Story [164d]
- MannKind (MNKD) Secures $500M Financing to Advance Inhaled Therapies Pipeline [164d]
- OPKO Health (OPK) Advances EBV Vaccine and GLP-1 Pipeline While Streamlining Diagnostics [164d]
- LifeStance Health (LFST) Accelerates Growth with AI-Enabled Operations and Clinician Expansion [164d]
- Australia's NAB sees $85 million cost increase to fix staff underpay issue [164d]
- Recursion Pharmaceuticals (RXRX) Expands AI Drug Discovery Pipeline with New Clinical Candid [164d]
- Why Analysts Say a Chrome Divestiture Could Hurt Alphabet (GOOGL) [164d]
- Medical Properties Trust (MPW) Raises $500M to Strengthen Balance Sheet [164d]
- Why Analysts Remain Cautious on CoreWeave (CRWV) Despite Strong Growth [164d]
- AbCellera Biologics (ABCL) Advances Proprietary Pipeline with Promising Phase 1 Trial Results [164d]
- Neogen Corp (NEOG) Beats Expectations Amid Leadership Change and Restructuring Efforts [164d]
- Tilray Brands (TLRY) Boosts Revenue Mix with New Cannabis, Wellness, and Beverage Products [164d]
- Cronos Group (CRON) Posts Double-Digit Cannabis Growth and Expands International Footprint [164d]
- I Asked ChatGPT How To Turn $10 Into $1 Million: Here’s What It Said [164d]
- Prediction: Nvidia's New China Deal Will Be a Game-Changer. Here's Why [164d]
- ImmunityBio (IBRX) Reports 60% Revenue Growth as ANKTIVA Adoption Accelerates [164d]
- Vistra (VST) Projects $6 Billion EBITDA as AI Data Centers Drive Power Demand Surge [164d]
- Constellation Energy (CEG) Strikes 20-Year PPA with Meta, Boosts Nuclear Expansion Plans [164d]
- NextEra Energy (NEE) to Invest $120 Billion in Renewables and Storage Through 2029 [164d]
- Duke Energy (DUK) Reports Nearly $1 Billion Profit, Eyes $87 Billion Growth Plan [164d]
- Why Amazon’s (AMZN) Diversification Strategy Keeps It on Wall Street’s Radar [164d]
- Citi Reiterates Buy on Microsoft (MSFT), Calls It a Top Software Pick [164d]
- Piper Sandler Raises NVIDIA (NVDA) Price Target to $225 Ahead of Earnings [164d]
- Wall Street Remains Bullish on Apple (AAPL) Amid AI Upside and Resilient Earnings [164d]
- 4 Ways To Scam-Proof Yourself When Getting Into Crypto Investing [164d]
- Evercore Maintains Bullish Stance on Palo Alto (PANW) as Investors Look Past CyberArk Deal [164d]
- Amazon.com, Inc. (AMZN) Is The Largest Position In My Trust, Says Jim Cramer [164d]
- FedEx Corporation (FDX) Has A Warehouse With No People, Says Jim Cramer [164d]
- I Like Cisco Systems, Inc. (CSCO) Because Of Its AI Business, Says Jim Cramer [164d]
- Palantir Technologies Inc. (PLTR) Could Help With Government Functioning, Says Jim Cramer [164d]
- NVIDIA Corporation (NVDA): I Spend A Lot Of Time Shooting Down Rumors, Says Jim Cramer [164d]
- Advanced Micro Devices, Inc. (AMD) Is Good But The Stock Shouldn’t Have Risen Recently, Says Jim Cramer [164d]
- Constellation Brands, Inc. (STZ)’s “A Terrible Stock,” Says Jim Cramer [164d]
- Diageo plc (DEO): Use The Bounce In Share Price To Sell, Says Jim Cramer [164d]
- Brown-Forman Corporation (BF-B): Use The Bounce In Share Price To Sell, Says Jim Cramer [164d]
- Wells Fargo Says DELL Has ‘More Room to Run’ as AI Server Leader [164d]
- Interactive Brokers Group, Inc. (IBKR): “There’s Just No Fluidity,” Says Jim Cramer [164d]
- Bullish (BLSH): I Was Okay With Stock Coming Down A Little, Says Jim Cramer [164d]
- Robinhood Markets, Inc. (HOOD): “The Numbers Are Extraordinary,” Says Jim Cramer [164d]
- Tapestry, Inc. (TPR) Was “Kind Of, Quizzical,” Says Jim Cramer [164d]
- Ulta Beauty, Inc. (ULTA): I Thought The Target Partnership Ending Was Very Significant [164d]
- Target Corporation (TGT): I Thought The Ulta Beauty Partnership Ending Was Very Significant [164d]
- CrowdStrike Holdings, Inc. (CRWD)’s CEO Is “Incredibly Competitive,” Says Jim Cramer [164d]
- Jim Cramer Warns About “A Lot Of Selling” In CoreWeave, Inc. (CRWV) [164d]
- CVS Health Corporation (CVS) Is “The Last Man Standing,” Says Jim Cramer [164d]
- UBS Resumes Coverage on Elastic (ESTC) With Buy Rating, $95 Price Target [164d]
- Walgreens Boots Alliance, Inc. (WBA)’s Shutting Down A Lot Of Stores, Says Jim Cramer [164d]
- The Sherwin-Williams Company (SHW): I Like It, But You’ve Got To Be Careful, Says Jim Cramer [164d]
- The Home Depot, Inc. (HD) Is A Thesis Play On Rate Cuts, Says Jim Cramer [164d]
- Can I Have A Reason To Buy Dow Inc. (DOW)? Asks Jim Cramer [164d]
- Ralph Lauren Corporation (RL)’s Isn’t “As Analogous” To Tapestry As You Think, Says Jim Cramer [164d]
- The TJX Companies, Inc. (TJX): Jim Cramer Isn’t As Worried About Tariffs As Wall Street [164d]
- After Explosive Gains, CoreWeave (CRWV) Gets Neutral Nod from Mizuho [164d]
- Nvidia quietly buys more stock in AI infrastructure favorite [164d]
- BigBear.ai (BBAI) Partners with DEFCON AI to Deliver Next-Gen Military Decision Intelligence Solutions [164d]
- Oppenheimer Downgrades C3.ai (AI) Amid Weak Results and Leadership Change [164d]
- Americans are hoarding more cash, but not in checking or savings. Here are the accounts rewarding savers today [164d]
- No new articles in the Past 3 Hours.
- No new articles in the Past 3 Hours.
- No new articles in the Past 3 Hours.
- No new articles in the Past 3 Hours.
- No new articles in the Past 3 Hours.
Previous Day